Overall, the significantly enriched predicted targets were found to be involved in apoptosis, hematopoiesis, acute myeloid leukemia, the JAK-STAT-, MAPK-, p53-, and chemokine signaling pathways, the spliceosome, and several cancers. This evidence concerns the gene TP53 and acute myeloid leukemia.